Animal & Veterinary
-
Swine
Breeding Swine
Feral Swine
Finishing Swine
Growing Swine
Piglets
Swine
| Active Ingredient | NADA/ANADA | Label Type | Indications |
|---|---|---|---|
| Chlortetracycline | N046-699 | Type C | Breeding swine: For control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline. |
| Ivermectin, Bacitracin Methylene Disalicylate | N141-097 | Type C | For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice, and mange mites. For control of clostridial enteritis caused by C. perfringens in suckling piglets. |
| Neomycin Sulfate and Oxytetracycline | N138-939 | Type C | For control and treatment of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline. |
| Active Ingredient | NADA/ANADA | Label Type | Indications |
|---|---|---|---|
| Fenbendazole | N131-675 | Type C | For the control and removal of kidney worms (Stephanurus dentatus), round worms (Ascaris suum), and nodular worms (Oesophagostomum dentatum) |
| Active Ingredient | NADA/ANADA | Label Type | Indications |
|---|---|---|---|
| Ractopamine and Tylosin | N141-172 | Type B | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs...; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis. |
| Ractopamine and Tylosin | N141-172 | Type B | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs...; and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis. |
| Ractopamine and Tylosin | N141-172 | Type B | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, ...; the treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis. |
| Ractopamine and Tylosin | N141-172 | Type C | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, ...; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis. |
| Ractopamine and Tylosin | N141-172 | Type C | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs... and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis. |
| Ractopamine and Tylosin | N141-172 | Type C | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs...; for treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis. |
| Active Ingredient | NADA/ANADA | Label Type | Indications |
|---|---|---|---|
| Chlortetracycline | N046-699 | Type C | For an increased rate of weight gain and improved feed efficiency in growing swine. |
| Active Ingredient | NADA/ANADA | Label Type | Indications |
|---|---|---|---|
| Ivermectin, Bacitracin Methylene Disalicylate | N141-097 | Type B | For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, threadworms, lice and mange mites. For control of clostridial enteritis caused by C. perfringens in suckling piglets. |
| Neomycin Sulfate | N140-976 | Type C | For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in calves, piglets, lambs and goat kids. |
| Active Ingredient | NADA/ANADA | Label Type | Indications |
|---|---|---|---|
| Bacitracin Zinc | A200-223 | Type B | For increased rate of weight gain and improved feed efficiency in growing and finishing swine. |
| Bacitracin Zinc | A200-223 | Type C | For increased rate of weight gain and improved feed efficiency in growing and finishing swine. |
| Carbadox | N041-061 | Type B | For control of swine dysentery (vibrionic dysentery, bloody scours by hemorrhagic dysentery); control of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis); increased rate of weight gain and improved feed efficiency. |
| Carbadox | N041-061 | Type B | For increased rate of weight gain and improved feed efficiency. |
| Carbadox | N041-061 | Type C | For control of swine dysentery (vibrionic dysentery, bloody scours of hemorrhagic dysentery); control of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis); increased rate of weight gain and improved feed efficiency. |
| Carbadox | N041-061 | Type C | For increased rate of weight gain and improved feed efficiency. |
| Carbadox and Oxytetracycline | N141-211 | Type C | Treatment of bacterial enteritis ... and treatment of bacterial pneumonia ... and increased rate of weight gain and improved feed efficiency. |
| Chlortetracycline | N046-699 | Type B | For control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis... For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida organisms. |
| Chlortetracycline | N046-699 | Type C | For reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci. |
| Chlortetracycline | N046-699 | Type C | For control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis...For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida organisms. |
| Chlortetracycline and Bacitracin Methylene Disalicylate | N141-059 | Type B | For increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis ..., and for control of porcine proliferative enteropathies (ileitis)... |
| Chlortetracycline and Bacitracin Methylene Disalicylate | N141-059 | Type B | For increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis ..., and for control of porcine proliferative enteropathies (ileitis) ... |
| Chlortetracycline and Bacitracin Methylene Disalicylate | N141-059 | Type C | For increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis ... , and for control of porcine proliferative enteropathies (ileitis) ... |
| Ivermectin, Bacitracin Methylene Disalicylate | N141-097 | Type C | For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, threadworms, lice and mange mites. For increased rate of weight gain and improved feed efficiency in growing finishing swine. |
| Ivermectin, Bacitracin Methylene Disalicylate | N141-097 | Type B | For the treatment and control of gastrointestinal roundworms, kidneyworms, lice, and mange mites. For increased rate of weight gain and improved feed efficiency in growing and finishing swine. |
| Ivermectin, Bacitracin Methylene Disalicylate | N141-097 | Type B | For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice, and mange mites. For increased rate of weight gain and improved feed efficiency in growing and finishing swine. |
| Ivermectin, Bacitracin Methylene Disalicylate | N141-097 | Type C | For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice, and mange mites. For control of swine dysentery associated with Treponema hyodysenteriae on premises with a history of swine dysentery but where signs of disease have not yet occurred; or following an approved treatment of the disease condition. |
| Ivermectin, Bacitracin Methylene Disalicylate | N141-097 | Type C | For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice, and mange mites. For increased rate of weight gain and improved feed efficiency in growing and finishing swine. |
| Ivermectin, Bacitracin Methylene Disalicylate | N141-097 | Type B | For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice, and mange mites. For control of swine dysentery associated with Treponema hyodysenteriae on premises with a history of swine dysentery but where signs of the disease have not yet occurred; or following an approved treatment of the disease condition. |
| Ivermectin and Lincomycin | N141-054 | Type C | For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice, and mange mites. Treatment of swine dysentery. |
| Ivermectin, Lincomycin | N141-054 | Type B | For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice and mange mites. For reduction in the severity of swine mycoplasmal pneumonia caused by Mycoplasma hyopneumoniae. |
| Ivermectin, Lincomycin | N141-054 | Type B | For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice and mange mites. For control of swine dysentery. |
| Ivermectin, Lincomycin | N141-054 | Type B | For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice and mange mites. For increase in rate of weight gain in growing-finishing swine. |
| Ivermectin, Lincomycin | N141-054 | Type C | For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice and mange mites. For reduction in the severity of swine mycoplasmal pneumonia caused by Mycoplasma hyopneumoniae. |
| Ivermectin, Lincomycin | N141-054 | Type C | For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice and mange mites. Increased rate of weight gain in growing-finishing swine. |
| Ivermectin, Lincomycin | N141-054 | Type C | For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms and mange mites. Control of swine dysentery; for use in swine on premises with a history of swine dysentery, but where symptoms have not yet occurred. |
| Ivermectin, Lincomycin | N141-054 | Type B | For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice and mange mites. For the treatment and control of swine dysentery. |
| Lincomycin | N097-505 | Type C | For reduction in the severity of swine mycoplasmal pneumonia caused by Mycoplasma hyopneumoniae. |
| Lincomycin | N097-505 | Type B | For the treatment and control of swine dysentery and the control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis. For reduction in the severity of swine mycoplasmal pneumonia caused by Mycoplasma hyopneumoniae. For increase in rate of weight gain in growing-finishing swine. |
| Lincomycin (Swine Ration L100) | N097-505 | Type C | For treatment of swine dysentery and the control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis. |
| Lincomycin (Swine Ration LC) | N097-505 | Type C | For control of swine dysentery and the control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis. |
| Lincomycin (Swine Ration L20) | N097-505 | Type C | For increase in rate of weight gain in growing-finishing swine. |
| Neomycin Sulfate | N140-976 | Type B | For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in cattle, swine, sheep and goats. |
| Neomycin Sulfate | N140-976 | Type C | For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in cattle, swine, sheep and goats. |
| Neomycin Sulfate and Oxytetracycline | N138-939 | Type B | For increased rate of weight gain and improved feed efficiency....treatment and control of bacterial enteritis...and bacterial pneumonia...treatment and control of colibacillosis...control and treatment of leptospirosis... |
| Neomycin Sulfate and Oxytetracycline | N138-939 | Type C | For increased rate of weight gain and improved feed efficiency. |
| Neomycin Sulfate and Oxytetracycline | N138-939 | Type C | For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis... |
| Oxytetracycline | N138-938 | Type B | For increased rate of weight gain and improved feed efficiency; treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida; control and treatment of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona. |
| Oxytetracycline | N138-938 | Type C | For increased rate of weight gain and improved feed efficiency. |
| Oxytetracycline | N138-938 | Type C | For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida. |
| Oxytetracycline | N138-938 | Type C | For control and treatment of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline. |
| Ractopamine and Tylosin | N141-172 | Type C | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine...; control of swine dysentery associated with Brachyspira hyodysenteriae; and control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis. |
| Ractopamine and Tylosin | N141-172 | Type C | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine...; and control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis. |
| Tiamulin | N139-472 | Type B | For control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis; control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin; treatment of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin. |
| Tiamulin | N139-472 | Type C | For control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis and for control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin; treatment of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin. |
| Tilmicosin | N141-064 | Type C | For the control of swine respiratory disease associated with Actinobacillus pleuropneumoniae and Pasteurella multocida. |
| Tilmicosin | N141-064 | Type B | For the control of swine respiratory disease associated with Actinobacillus pleuropneumoniae and Pasteurella multocida. |
| Tylosin | A200-484 | Type C | For control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis. |
| Tylosin | A200-484 | Type B | For control of swine dysentery associated with Brachyspira hyodysenteriae. |
| Tylosin | A200-484 | Type C | For control of swine dysentery associated with Brachyspira hyodysenteriae. |
| Tylosin and Sulfamethazine | N041-275 | Type B | For maintaining weight gains and feed efficiency in the presence of atrophic rhinitis; lowering the incidence and severity of bordetella bronchiseptica rhinitis; prevention of swine dysentery associated with Brachyspira hyodysenteriae; control of swine pneumonias caused by bacterial pathogens (Pasteurella multocida and/or Arcanobacterium pyogenes). |
| Tylosin and Sulfamethazine | N041-275 | Type C | For maintaining weight gains and feed efficiency in the presence of atrophic rhinitis; lowering the incidence and severity bordetella bronchiseptica rhinitis; prevention of swine dysentery associated with Brachyspira hyodysenteriae; control of swine pneumonias caused by bacterial pathogens (Pasteurella multocida and/or Arcanobacterium pyogenes). |
| Virginiamycin | N091-467 | Type B | Increased rate of weight gain and improved feed efficiency; aid in the control of swine dysentery... for use in animals or on premises with a history of swine dysentery, but where symptoms have not yet occurred; treatment and control of swine dysentery. |
| Virginiamycin | N091-467 | Type B | Increased rate of weight gain and improved feed efficiency; aid in the control of swine dysentery... for use in animals or on premises with a history of swine dysentery, but where symptoms have not yet occurred; treatment and control of swine dysentery. |
| Virginiamycin | N091-467 | Type C | Increased rate of weight gain and improved feed efficiency... |
| Virginiamycin | N091-467 | Type C | As an aid in the control of swine dysentery in swine weighing up to 120 lb. For use in animals or on premises with a history of swine dysentery, but where symptoms have not yet occurred. |
| Virginiamycin | N091-467 | Type C | For treatment and control of swine dysentery in swine weighing up to 120 lb. |
| Virginiamycin | N091-467 | Type C | For treatment and control of swine dysentery in non-breeding swine weighing over 120 lb. |
| Virginiamycin | N091-467 | Type C | Increased rate of weight gain and improved feed efficiency... |
| Virginiamycin | N091-467 | Type C | As an aid in the control of swine dysentery in swine weighing up to 120 lb. For use in animals or on premises with a history of swine dysentery, but where symptoms have not yet occurred. |
| Virginiamycin | N091-467 | Type C | For treatment and control of swine dysentery in swine weighing up to 120 lb. |
| Virginiamycin | N091-467 | Type C | For treatment and control of swine dysentery in non-breeding swine weighing over 120 lb. |
-
-
